Mieloma múltiplo: entenda câncer da medula óssea e avanços na medicina

[{"selector":"#anim-9cf5e653-abf5-4f00-9344-b699cb8298da","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f545fd14-8e9a-4229-885e-aed42ad45f8f","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-fbd51579-8bb1-448a-961f-8fc44777ae24","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-76fd3420-084a-4b73-a75f-638f0c919401","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] www.kaboompics.com/Pexels

[{"selector":"#anim-36752d1d-d6f8-487a-847a-afecdd0024fd","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e4ef8b16-d175-4623-ab15-99fb66b4c121","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d8da1228-4522-459d-bcd7-910e8cd10e55","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-d3f09ed3-448a-4ffe-a318-b9f1642520b3","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-bf7ec328-71aa-4e90-869f-02d92f4c90d6 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] A perspectiva de vida para pacientes com mieloma múltiplo , um tipo de câncer do sangue que afeta a medula óssea, registrou um avanço significativo nas últimas décadas Freepick

[{"selector":"#anim-a493338f-4ed5-4440-96e2-d3b2bd9d460b","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3b9f1a13-b8c3-4218-a612-d266dc31f2e4","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-dac9aeea-b88a-4a34-9264-5540f8542d40","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-76911684-a9b7-4479-972e-c5fe991ea0de","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-3d9f7f9f-d356-4999-8d56-f80aea5d1ea7 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-7.812499744007886%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] A chance de um paciente estar vivo cinco anos após o diagnóstico dobrou, passando de 32% para 62%. O dado foi divulgado no relatório anual "Cancer Statistics 2026", da American Cancer Society Tima Miroshnichenko/Pexels

[{"selector":"#anim-21cede52-c7f9-4b15-a12c-d81cc8913d7a","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bc0fde6c-f9ff-454c-941c-c6aaacc2c140","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f3de9e39-ce36-43cd-9ddf-83ceda27d9ae","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-42101b3f-8a80-45a1-9053-4b50e1fcdad2","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-414762c7-7a8d-4df3-a54c-cf6086559da8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(7.807055493103773%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Até os anos 1970, a sobrevida mediana para pacientes com mieloma múltiplo era de aproximadamente 20 meses, com tratamentos baseados exclusivamente em quimioterapia RDNE Stock project/Pexels

[{"selector":"#anim-625033d4-aaa6-432a-a8fc-f233531be730","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b4f5095c-b6bf-4f38-9cec-46b57ea9c682","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5488234b-f6e0-4cc4-a634-7701a47ff397","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-80ce751f-55bc-45ad-b114-5d0e1bc77bf7","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-a0d23d61-aa21-4086-aae1-542e3ececccc [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(27.78832607624871%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Hoje, a introdução de terapias como o transplante autólogo (procedimento que utiliza as próprias células-tronco do paciente para restaurar a medula óssea após quimioterapia de alta dose), imunoterapias e anticorpos biespecíficos, transformou o cenário RDNE Stock project/Pexels

[{"selector":"#anim-49d6ab4d-9a24-4252-97c9-8292d9c8f179","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-111bc8c7-6b57-4eb9-8510-3c7d9f7297d6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0b2269bf-69eb-4ef3-9c29-f85b8815eb97","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-2028e4db-63f1-4289-8599-7668ef5550a8","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-da855296-2962-4ad2-9729-2ecc461dadf9 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-7.812499744007886%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] A médica Vânia Hungria, hematologista, explica a complexidade da doença e a importância do diagnóstico precoce. O mieloma múltiplo é um câncer da medula óssea, onde plasmócitos malignos se acumulam, levando a sintomas como dores nas costas, anemia e alterações renais www.kaboompics.com/Pexels

[{"selector":"#anim-4e3336f5-92c4-4f1c-b70f-00780570d2f3","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-4add9e3e-b0c3-4c29-bcc9-2eb4b81fc9fb","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e8bc054e-7519-4d53-8769-9523ab99fbb2","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-3d4173ce-1ff1-4b50-9cac-c06e6cac3db3","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-ac845fb6-4280-44a8-beb0-0eb602dc7da8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(28.90624987200394%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] A especialista ressalta o impacto das novas abordagens de tratamento. "Hoje, nós temos muitas opções terapêuticas, como anticorpos monoclonais, anticorpos biespecíficos, CAR-T cells. É uma inovação enorme para o tratamento dos pacientes com mieloma múltiplo", afirma Vânia Hungria Engin Akyurt/Pexels

CNNBRASIL.COM.BR

[{"selector":"#anim-59a68eb6-e7b5-41fe-bb04-2468aacc4587","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cbd4abd1-6462-48c4-8577-6d86ff0d755b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-29b99549-a53f-4564-a679-0a9bcadf212e","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8e10123f-f61f-4b7b-880a-101de1c4c001","keyframes":{"transform":["translate3d(0px, 2132.63615%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d3ea3b94-a006-477b-b74a-d3a132902d8a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5ff1017e-3c22-4446-aa72-61a4c0be1eff","keyframes":{"transform":["translate3d(-117.84387%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d9d1cf78-02cf-4612-b467-10c4be2c85b4","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e08bff2c-ec87-4a82-8641-c52cd3280132","keyframes":{"transform":["translate3d(0px, 870.06218%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] www.kaboompics.com/Pexels leia mais em